In a bold move that has raised eyebrows in the imaging industry, HYB Group recently announced significant upgrades to its Zhuhai Toner Laboratory. While the company touts the expansion as a step toward improving toner quality and meeting “OEM-equivalent” standards, industry insiders and skeptics are raising concerns. Could this lab upgrade be a strategic ploy to push more fake clone toners into global markets?

The upgrades include the installation of additional copier machines for extensive bench testing and a new chemical analysis lab designed to refine toner formulations. These investments aim to ensure HYB’s products deliver performance on par with OEM (original equipment manufacturer) toners. While HYB’s press release positions the move as a commitment to quality, it’s hard to ignore the potential for misuse.
For one, the sheer scale of these upgrades provides HYB the technical ability to closely replicate the toner formulas of big-name brands. With the growing global demand for cheaper alternatives to expensive OEM cartridges, HYB could be well-positioned to supply perfectly crafted “clone” toners that perform just like the real deal — at a fraction of the price. And that’s where the controversy kicks in.
Aftermarket toners, while legal in many markets, often walk a fine line between legitimate alternatives and counterfeit products. In some regions, where enforcement is lax, clone toners are rebranded, misrepresented, or sold without proper regulatory oversight. HYB, with its expanded lab capabilities, may be inadvertently (or strategically) increasing the risk of counterfeit products flooding the market under the guise of OEM-quality toner.
There is also the unsettling reality that counterfeiters have previously used HYB’s name to sell subpar products, raising questions about whether these lab upgrades could enable others to jump on the bandwagon, creating even more “fake” toners disguised as legitimate alternatives.
While HYB insists its new facility will result in better quality and performance, the question remains: Is it genuinely about providing consumers with affordable alternatives, or is it a clever marketing move to dominate the global toner market — with the added benefit of an increasing supply of clone toners?
As the line between legitimate aftermarket products and counterfeits continues to blur, HYB’s latest upgrade could be seen as the thin edge of the wedge in a growing global trade of cloned toner products. The industry will be watching closely to see how this bold step impacts the market — and whether HYB is truly delivering value or simply fueling the demand for “fake” toners worldwide.